EQT Life Sciences is investing USD 17.5 million in Vaderis Therapeutics as part of the Swiss company's USD 152 million Series B financingThe financing ...
When a wound does not heal properly, it leaves a scar. Similarly, mutations—which are permanent changes to genetic code—are ...
The ability to quickly and affordably survey a patient's entire genome is expected to accelerate research, diagnostics, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results